Browse All

Current Filters

CLEAR FILTER x

TITLE

Response Trajectories of Patients with Parkinson’s Disease Psychosis Treated with Pimavanserin: An Exploratory Cluster Analysis

Author:Dashtipour, Khashayar   Espay, Alberto   Zhang, Peter   Abler, Victor   Brunson, Greg   Chrones, Lambros   

Session Name:P11: Aging, Dementia, and Behavioral Neurology: Synucleinopathies  

Topic:Aging, Dementia, and Behavioral Neurology  

Program Number:P11.006  

Author Institution:Department of Neurology, Loma Linda University School of Medicine, Loma Linda, CA  University of Cincinnati Gardner Neuroscience Institute, Gardner Family Center for Parkinson’s Disease and Movement Disorders, Department of Neurology, University of Cincinnati, Cincinnati, OH  Acadia Pharmaceuticals, Inc., North Potomac, MD  Acadia Pharmaceuticals, Inc., Cincinnati, OH  Acadia Pharmaceuticals, Inc., San Clemente, CA  Acadia Pharmaceuticals, Inc., Westmont, IL  

Impact of Baseline Sleep Disturbances on Pimavanserin Response in Parkinson’s Disease Psychosis: A Post Hoc Analysis

Author:Chrones, Lambros   Naujoks, Karla   Zhang, Peter   Feng, Xiaoshu   Brunson, Greg   Krystal, Andrew   

Session Name:P11: Aging, Dementia, and Behavioral Neurology: Synucleinopathies  

Topic:Aging, Dementia, and Behavioral Neurology  

Program Number:P11.007  

Author Institution:Acadia Pharmaceuticals, Inc., Westmont, IL  Acadia Pharmaceuticals, Inc., San Diego, CA  Acadia Pharmaceuticals, Inc., North Potomac, MD  Acadia Pharmaceuticals, Inc., San Clemente, CA  Departments of Psychiatry and Neurology, University of California - San Francisco, San Francisco, CA